A citation-based method for searching scientific literature

Theodoros Karampitsakos, Tony Woolard, Demosthenes Bouros, Argyris Tzouvelekis. Eur J Pharmacol 2017
Times Cited: 26







List of co-cited articles
271 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
34

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
30

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
26

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
617
23


Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
23

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
309
23

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
271
19

SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.
Argyrios Tzouvelekis, Guoying Yu, Christian L Lino Cardenas, Jose D Herazo-Maya, Rong Wang, Tony Woolard, Yi Zhang, Koji Sakamoto, Hojin Lee, Jae-Sung Yi,[...]. Am J Respir Crit Care Med 2017
35
19

Idiopathic pulmonary fibrosis: an update.
Paolo Spagnolo, Nicola Sverzellati, Giulio Rossi, Alberto Cavazza, Argyris Tzouvelekis, Bruno Crestani, Carlo Vancheri. Ann Med 2015
72
19

Personalized medicine in idiopathic pulmonary fibrosis: facts and promises.
Paolo Spagnolo, Argyris Tzouvelekis, Toby M Maher. Curr Opin Pulm Med 2015
29
19

Update on therapeutic management of idiopathic pulmonary fibrosis.
Argyris Tzouvelekis, Francesco Bonella, Paolo Spagnolo. Ther Clin Risk Manag 2015
44
19

Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment.
Hong-Zhen Yang, Bing Cui, Han-Zhi Liu, Zhi-Rong Chen, Hui-Min Yan, Fang Hua, Zhuo-Wei Hu. J Immunol 2009
69
19

TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury.
Hong-Zhen Yang, Jia-Ping Wang, Su Mi, Han-Zhi Liu, Bing Cui, Hui-Min Yan, Jun Yan, Zhe Li, Hong Liu, Fang Hua,[...]. Am J Pathol 2012
108
19

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
19

Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.
Jiurong Liang, Yanli Zhang, Ting Xie, Ningshan Liu, Huaiyong Chen, Yan Geng, Adrianne Kurkciyan, Jessica Monterrosa Mena, Barry R Stripp, Dianhua Jiang,[...]. Nat Med 2016
138
19

The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
David N O'Dwyer, Michelle E Armstrong, Glenda Trujillo, Gordon Cooke, Michael P Keane, Padraic G Fallon, A John Simpson, Ann B Millar, Emmet E McGrath, Moira K Whyte,[...]. Am J Respir Crit Care Med 2013
92
19

Idiopathic pulmonary fibrosis: on the move.
Demosthenes Bouros, Argyris Tzouvelekis. Lancet Respir Med 2014
19
21


Regulation of lung injury and repair by Toll-like receptors and hyaluronan.
Dianhua Jiang, Jiurong Liang, Juan Fan, Shuang Yu, Suping Chen, Yi Luo, Glenn D Prestwich, Marcella M Mascarenhas, Hari G Garg, Deborah A Quinn,[...]. Nat Med 2005
15

The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
Raphael Borie, Bruno Crestani, Philippe Dieude, Hilario Nunes, Yannick Allanore, Caroline Kannengiesser, Paolo Airo, Marco Matucci-Cerinic, Benoit Wallaert, Dominique Israel-Biet,[...]. PLoS One 2013
104
15

MUC5B promoter polymorphism and interstitial lung abnormalities.
Gary M Hunninghake, Hiroto Hatabu, Yuka Okajima, Wei Gao, Josée Dupuis, Jeanne C Latourelle, Mizuki Nishino, Tetsuro Araki, Oscar E Zazueta, Sila Kurugol,[...]. N Engl J Med 2013
233
15


Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
Tasha E Fingerlin, Elissa Murphy, Weiming Zhang, Anna L Peljto, Kevin K Brown, Mark P Steele, James E Loyd, Gregory P Cosgrove, David Lynch, Steve Groshong,[...]. Nat Genet 2013
422
15

A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis.
Yingze Zhang, Imre Noth, Joe G N Garcia, Naftali Kaminski. N Engl J Med 2011
137
15

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
641
15

Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient's "Q and A" approach.
Argyris Tzouvelekis, Vasilios Tzilas, Spyridon Papiris, Vassilis Aidinis, Demosthenes Bouros. Pulm Pharmacol Ther 2017
17
23

Lung cancer in patients with idiopathic pulmonary fibrosis.
Theodoros Karampitsakos, Vasilios Tzilas, Rodoula Tringidou, Paschalis Steiropoulos, Vasilis Aidinis, Spyros A Papiris, Demosthenes Bouros, Argyris Tzouvelekis. Pulm Pharmacol Ther 2017
68
15

The safety of new drug treatments for idiopathic pulmonary fibrosis.
Sophie Fletcher, Mark G Jones, Katherine Spinks, Giacomo Sgalla, Ben G Marshall, Rachel Limbrey, Luca Richeldi. Expert Opin Drug Saf 2016
13
30

Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function.
Guoying Yu, Argyris Tzouvelekis, Rong Wang, Jose D Herazo-Maya, Gabriel H Ibarra, Anup Srivastava, Joao Pedro Werneck de Castro, Giuseppe DeIuliis, Farida Ahangari, Tony Woolard,[...]. Nat Med 2018
138
15

Interstitial lung disease in connective tissue disease--mechanisms and management.
Athol U Wells, Christopher P Denton. Nat Rev Rheumatol 2014
86
15

The pathogenesis of pulmonary fibrosis: a moving target.
Wim A Wuyts, Carlo Agostini, Katerina M Antoniou, Demosthenes Bouros, Rachel C Chambers, Vincent Cottin, Jim J Egan, Bart N Lambrecht, Rik Lories, Helen Parfrey,[...]. Eur Respir J 2013
155
15


Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study.
Giorgos A Margaritopoulos, Katerina M Antoniou, Kostas Karagiannis, Katerina D Samara, Ismini Lasithiotaki, Evi Vassalou, Rena Lymbouridou, Helen Koutala, Nikos M Siafakas. Fibrogenesis Tissue Repair 2010
27
15

Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Katerina D Samara, Katerina M Antoniou, Konstantinos Karagiannis, Georgios Margaritopoulos, Ismini Lasithiotaki, Eleni Koutala, Nikolaos M Siafakas. Int J Oncol 2012
56
15

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.
Moises Selman, Annie Pardo, Lourdes Barrera, Andrea Estrada, Susan R Watson, Keith Wilson, Natasha Aziz, Naftali Kaminski, Albert Zlotnik. Am J Respir Crit Care Med 2006
322
11

Epigenetics in idiopathic pulmonary fibrosis.
Argyrios Tzouvelekis, Naftali Kaminski. Biochem Cell Biol 2015
49
11

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.
Brigham C Willis, Janice M Liebler, Katherine Luby-Phelps, Andrew G Nicholson, Edward D Crandall, Roland M du Bois, Zea Borok. Am J Pathol 2005
675
11

Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis.
Argyris Tzouvelekis, Jose Herazo-Maya, Koji Sakamoto, Demosthenes Bouros. Curr Top Med Chem 2016
24
12

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
Luca Richeldi, Vincent Cottin, Roland M du Bois, Moisés Selman, Toshio Kimura, Zelie Bailes, Rozsa Schlenker-Herceg, Susanne Stowasser, Kevin K Brown. Respir Med 2016
210
11

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
Yongyu Wang, Phillip J Kuan, Chao Xing, Jennifer T Cronkhite, Fernando Torres, Randall L Rosenblatt, J Michael DiMaio, Lisa N Kinch, Nick V Grishin, Christine Kim Garcia. Am J Hum Genet 2009
289
11

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
Bridget D Stuart, Joyce S Lee, Julia Kozlitina, Imre Noth, Megan S Devine, Craig S Glazer, Fernando Torres, Vaidehi Kaza, Carlos E Girod, Kirk D Jones,[...]. Lancet Respir Med 2014
148
11

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
Na Xie, Zheng Tan, Sami Banerjee, Huachun Cui, Jing Ge, Rui-Ming Liu, Karen Bernard, Victor J Thannickal, Gang Liu. Am J Respir Crit Care Med 2015
184
11

Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
Ilias C Papanikolaou, Kyriaki A Boki, Evangelos J Giamarellos-Bourboulis, Antigoni Kotsaki, Konstantinos Kagouridis, Napoleon Karagiannidis, Vlasis S Polychronopoulos. Immunol Lett 2015
11
27

TLR4 is a negative regulator in noninfectious lung inflammation.
Hang Zhao, Shaw-Wei Leu, Liyun Shi, Rejmon Dedaj, Gaofeng Zhao, Hari G Garg, Lianjun Shen, Egil Lien, Katherine A Fitzgerald, Aviva Shiedlin,[...]. J Immunol 2010
40
11

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie, Martin Kolb. Int J Biochem Cell Biol 2008
571
11

Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice.
Alexandra Paun, Jessica Fox, Viviane Balloy, Michel Chignard, Salman T Qureshi, Christina K Haston. Int J Radiat Oncol Biol Phys 2010
44
11

Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
Jonathan K Alder, Julian J-L Chen, Lisa Lancaster, Sonye Danoff, Shu-chih Su, Joy D Cogan, Irma Vulto, Mingyi Xie, Xiaodong Qi, Rubin M Tuder,[...]. Proc Natl Acad Sci U S A 2008
469
11


The innate immune function of airway epithelial cells in inflammatory lung disease.
Pieter S Hiemstra, Paul B McCray, Robert Bals. Eur Respir J 2015
186
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.